bioQuad Life Sciences Issues Allergy Alert on Undeclared Milk in OsteoDenx® Dietary Supplement
OsteoDenx capsules
Manually maintained record
An editor supplied or changed this record. These edits have not been verified by the agency. Last edited: 2026-11-14T01:46:23.508Z. The underlying agency record was last checked on 2026-11-14T04:48:52.330Z; that check does not verify the manual edits.
What is the scope of this recall record?
This page includes manual edits. The source-check date applies only to the underlying FDA announcement, not the edits.
This announcement was last checked against the FDA source on 2026-11-14. Check the official FDA announcement or contact the firm for current instructions; this page does not establish that a product is safe or that the recall is complete. The company's announcement date, FDA publication date and this site's first observation are recorded separately.
Reported risk
Undeclared milk from cow’s-milk-derived lactoferrin. People with a milk allergy or severe sensitivity may have a serious or life-threatening allergic reaction. The announcement states that no illnesses had been reported to date.
What should I do if I have this product?
Consumers allergic or sensitive to milk should not take the affected product and may discard it. Purchasers of the affected lots may request a full refund or replacement in corrected packaging. Check the lot and expiration date on the carton side panel; this recall covers two lots, not all OsteoDenx products.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
The product description and identifiers below were supplied or edited by a person. Confirm them with the agency notice or the firm before relying on a match; missing information does not establish that your product is unaffected.
Which lot codes, UPCs or models are affected?
Product | UPC | Lot | Expiration
OsteoDenx® 30 capsules (17.85 g) | 8 57294 00722 8 | LOT#0524100 | 05/2027
OsteoDenx® 30 capsules (17.85 g) | 8 57294 00722 8 | LOT#0625041 | 08/2028
OsteoDenx® 60 capsules (35.7 g) | 8 57294 00734 1 | LOT#0524100 | 05/2027
OsteoDenx® 60 capsules (35.7 g) | 8 57294 00734 1 | LOT#0625041 | 08/2028
- Agency record number
- news-431032
- Affected products
- Product | UPC | Lot | Expiration OsteoDenx® 30 capsules (17.85 g) | 8 57294 00722 8 | LOT#0524100 | 05/2027 OsteoDenx® 30 capsules (17.85 g) | 8 57294 00722 8 | LOT#0625041 | 08/2028 OsteoDenx® 60 capsules (35.7 g) | 8 57294 00734 1 | LOT#0524100 | 05/2027 OsteoDenx® 60 capsules (35.7 g) | 8 57294 00734 1 | LOT#0625041 | 08/2028
- Company
- bioQuad Life Sciences
- Quantity
- Not provided
- Distribution
- United States nationwide, through bioquad.com, Amazon.com, resellers and a dental clinic in Redwood City, California. Distribution period: November 1, 2024 to November 11, 2026.
- Models
- Not provided
- Contact
- bioQuad Life Sciences: (714) 660-1031, Monday–Friday, 9:30 a.m.–5 p.m. Pacific Time; [email protected]. Emails outside business hours or on weekends are answered the next business day.
- FDA announcement ID
- 431032
- Product
- OsteoDenx capsules
- FDA published
- November 13, 2026
- Company announced
- November 13, 2026
- Agency
- FDA
FDA company announcement
bioQuad Life Sciences of Yorba Linda, California is recalling two lots of OsteoDenx® dietary supplement capsules because they contain undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume this product.
The product was distributed nationwide and reached consumers through online orders at bioquad.com and Amazon.com, resellers, and a dental clinic in Redwood City, California, from November 1, 2024 to November 11, 2026.
OsteoDenx® comes in a paperboard carton of 30 or 60 capsules, shown in the photos below. The lot number and expiration date are printed on the side panel of the carton.
| Product | UPC | Lot | Expiration |
| OsteoDenx® 30 capsules (17.85 g) | 8 57294 00722 8 | LOT#0524100 | 05/2027 |
| OsteoDenx® 30 capsules (17.85 g) | 8 57294 00722 8 | LOT#0625041 | 08/2028 |
| OsteoDenx® 60 capsules (35.7 g) | 8 57294 00734 1 | LOT#0524100 | 05/2027 |
| OsteoDenx® 60 capsules (35.7 g) | 8 57294 00734 1 | LOT#0625041 | 08/2028 |
No illnesses have been reported to date.
The issue was identified during a routine FDA inspection. The capsules contain lactoferrin derived from cow's milk. Distribution has stopped until corrected cartons are available.
Consumers who are allergic or sensitive to milk should not take the product and may discard it. Customers who purchased the affected lots may request a full refund or a replacement in corrected packaging. Consumers with questions may contact the company at (714) 660-1031, Monday to Friday, 9:30 AM to 5:00 PM Pacific Time, or [email protected]. Emails received after business hours or on weekends will be answered the next business day.
This recall is being made with the knowledge of the U.S. Food and Drug Administration.